Alembic Pharmaceuticals informs about press release

02 May 2025 Evaluate
Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg. Enclosed the press release.  

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

768.00 -7.30 (-0.94%)
19-Jan-2026 11:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1678.50
Dr. Reddys Lab 1170.95
Cipla 1383.25
Zydus Lifesciences 866.45
Lupin 2176.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×